Detalhe da pesquisa
1.
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Cancer Immunol Immunother
; 70(5): 1255-1262, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130956
2.
Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study.
BMC Pediatr
; 15: 26, 2015 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25885437
3.
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Eur J Cancer
; 200: 113600, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330766
4.
Prognostic implication of PD-L1 in early-stage non-small cell lung cancer: a retrospective single-centre study.
Swiss Med Wkly
; 153: 40110, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769653
5.
Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.
Cancers (Basel)
; 14(17)2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077640
6.
Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy.
J Clin Med
; 11(6)2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35329953
7.
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial.
Lung Cancer
; 156: 91-99, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933896
8.
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.
J Clin Oncol
; 39(26): 2872-2880, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251873
9.
Recent developments and advances in secondary prevention of lung cancer.
Eur J Cancer Prev
; 29(4): 321-328, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452945
10.
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients.
Lung Cancer
; 148: 48-54, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799090
11.
SS18-bronchial biphasic synovial sarcoma in an octogenarian with hemothorax.
Lung
; 192(3): 451-3, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429587
12.
Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Front Med (Lausanne)
; 6: 336, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32118000
13.
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma.
J Thorac Oncol
; 13(11): 1784-1791, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142389
14.
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients.
Leuk Lymphoma
; 48(1): 104-8, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17325853
15.
Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs).
J Thorac Oncol
; 12(4): 681-688, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28007627
16.
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
Clin Lung Cancer
; 18(3): 303-309, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993482
17.
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.
Lancet Respir Med
; 5(5): 435-444, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408243
18.
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
J Clin Oncol
; 35(13): 1403-1410, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447912
19.
Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules.
Transl Lung Cancer Res
; 10(11): 4303-4307, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004258
20.
Management of non-small cell lung cancer in the elderly.
Eur J Intern Med
; 25(10): 888-94, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468247